Improving Outcomes and Mitigating Costs Associated With CAR T-Cell TherapyByRebecca Borgert, PharmD, BCOPAugust 18th 2021
Balancing the CAR T: Perspectives on Efficacy and Safety of CAR T-Cell Therapy in Hematologic MalignanciesByLarry W. Buie, PharmD, BCOP, FASHPAugust 18th 2021
